Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

FDA Regulations Reform? Risks and Benefit for the Approval Process of New Drugs

Posted on June 2nd, 2017 by in Pharma R&D

Know the rules

Since 1906, the US Food and Drug Administration (FDA) through regulations has been responsible for ensuring the approval of new drugs whose health benefits outweigh the known risks associated with the drug.

Continue reading “FDA Regulations Reform? Risks and Benefit for the Approval Process of New Drugs” »

Self-Promoting Scientists: Building Trust with the Public

Posted on May 31st, 2017 by in Pharma R&D

 

Scientist

At Sequencing the Genome: Examining Modern Medicine, an event recently held in New York City and sponsored by The Atlantic, a series of panelists spoke on many aspects of genomics ranging from its progress in treating disease to its potential for stopping epidemics Continue reading “Self-Promoting Scientists: Building Trust with the Public” »

Assessing the State of the Genomic Revolution

Posted on May 29th, 2017 by in Pharma R&D

A few weeks ago, a number of experts in the field of genomics gathered in downtown Manhattan for Sequencing the Genome: Examining Modern Medicine, an event hosted by The Atlantic magazine. Continue reading “Assessing the State of the Genomic Revolution” »

Top questions on the minds of QPPV

Posted on December 21st, 2016 by in Pharmacovigilance

The 2016 Pharmacovigilance Days (PHV Day 2016) kicked off in early April 2016 in Berlin, Germany. Afterwards, the tour continued to Amsterdam, London, Copenhagen, Rome and Paris in October and November. With the objective of bringing together safety experts from the pharmaceutical and healthcare industry Continue reading “Top questions on the minds of QPPV” »

  1. 1
  2. 2
  3. 3